Activity Description
This enduring educational activity is comprised of proceedings from an educational symposium held at ACC.19 in New Orleans.
Access Presentation
Webcast
Click on the session title listed below to view each presentation.
Session I: LAA Closure for Stroke Prevention |
|
Conceptual Basis of LAAC & Outcomes: Mortality and Net Clinical Benefit |
|
Device-Related Thrombus: Incidence, Management & Outcomes |
|
Why LAAC? Understanding Intracranial Hemorrhage Risk before It Happens |
|
Case Presentation: Watchman-Flex Implantation |
|
Panel Discussion |
|
Session II: AF-Related Stroke & Anticoagulation |
|
NOAC Use in “Special Populations”: CKD, Liver Disease, Obesity, Elderly |
|
Using NOAC Reversal Agents: When and How? |
|
Subclinical Atrial Fibrillation: Incidence and Management |
|
Panel Discussion |
Commercial Supporter
Educational support provided by:
Boston Scientific.
Faculty
Program Director
Vivek Reddy, MD |
Program Director
Valentin Fuster, MD, PhD, MACC |
|
Edip Gurol, MD, MSc |
|
Taya Glotzer, MD, FACC, FHRS |
|
Jonathan Halperin, MD |
|
Miguel Valderrábano, MD, FACC |
|
William Whang, MD |